From a Leukemia & Lymphoma Society (LLS) 2009 publication titled “Myeloma”:

“In the last five years, four new myeloma drugs have been approved; these may prove to be more effective than prior therapy options, or at least provide the same benefit, but with fewer side effects and more convenience for patients. This progress toward a cure is expected to continue as a result of the concerted scientific research effort that is under way and because of patients’ participation in clinical trials.”